4//SEC Filing
Ehrlich Christopher B 4
Accession 0001213900-24-105730
CIK 0001870404other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 9:13 PM ET
Size
5.8 KB
Accession
0001213900-24-105730
Insider Transaction Report
Form 4
Ehrlich Christopher B
DirectorChairman and CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-12-02+1,275,000→ 1,275,000 totalExercise: $0.10Exp: 2034-09-30→ Common Stock (1,275,000 underlying)
Footnotes (1)
- [F1]On October 1, 2024, the Reporting Person was granted an option to purchase 2,550,000 shares of Common Stock, which vest in two equal installments subject to the satisfaction of certain performance criteria. On December 2, 2024, the Issuer's Board of Directors confirmed that the performance criteria had been met with regards to one installment, resulting in the vesting of 1,275,000 shares.
Documents
Issuer
CERO THERAPEUTICS HOLDINGS, INC.
CIK 0001870404
Entity typeother
Related Parties
1- filerCIK 0001293973
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 9:13 PM ET
- Size
- 5.8 KB